CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
76 hedge funds and large institutions have $142M invested in Cascadian Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 20
Holders
76
Holding in Top 10
1
Calls
$273K
Puts
$85K
Top Buyers
| 1 | +$947K | |
| 2 | +$411K | |
| 3 | +$245K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$241K |
| 5 |
EWM
Edge Wealth Management
New York
|
+$164K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$1.03M | |
| 3 | -$549K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$427K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$337K |